Therapeutic effect of near infrared (NIR) light on Parkinson's disease models.
暂无分享,去创建一个
Michele Henry | Ellen Buchmann | Margaret Wong-Riley | M. Wong-Riley | H. Whelan | B. Quirk | Janis T Eells | Harry T Whelan | Brendan J Quirk | J. Eells | Kristina D Desmet | M. Henry | E. Buchmann | Kristina D. Desmet
[1] E. Junn,et al. Human α-Synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine , 2002, Neuroscience Letters.
[2] H. T. Whelan,et al. Near-infrared light via light-emitting diode treatment is therapeutic against rotenone- and 1-methyl-4-phenylpyridinium ion-induced neurotoxicity , 2008, Neuroscience.
[3] J. Bennett,et al. The cybrid model of sporadic Parkinson's disease , 2009, Experimental Neurology.
[4] M. Wong-Riley,et al. Photobiomodulation partially rescues visual cortical neurons from cyanide-induced apoptosis , 2006, Neuroscience.
[5] Keyoumars Ashkan,et al. Neuroprotection of midbrain dopaminergic cells in MPTP‐treated mice after near‐infrared light treatment , 2010, The Journal of comparative neurology.
[6] C. C. Johnson,et al. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living , 1998, Neurology.
[7] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[8] Noel T. Whelan,et al. NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients. , 2002, Journal of clinical laser medicine & surgery.
[9] M. Beal,et al. Parkinson's disease. , 2007, Human molecular genetics.
[10] M. Wong-Riley,et al. Light-emitting diode treatment reverses the effect of TTX on cytochrome oxidase in neurons , 2001, Neuroreport.
[11] Andrew B West,et al. Molecular pathophysiology of Parkinson's disease. , 2005, Annual review of neuroscience.
[12] P. Praamstra,et al. Genetic and environmental risk factors in Parkinson’s disease , 1998, Clinical Neurology and Neurosurgery.
[13] T. Sherer,et al. Environment, Mitochondria, and Parkinson's Disease , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[14] R. Gainetdinov,et al. Role of Dopamine Transporter in Methamphetamine-Induced Neurotoxicity: Evidence from Mice Lacking the Transporter , 1998, The Journal of Neuroscience.
[15] Britton Chance,et al. Photobiomodulation Directly Benefits Primary Neurons Functionally Inactivated by Toxins , 2005, Journal of Biological Chemistry.
[16] L. Tremblay,et al. Experimental Models of Parkinson’s Disease , 2002, Annales pharmaceutiques francaises.
[17] W. Dauer,et al. Parkinson's Disease Mechanisms and Models , 2003, Neuron.
[18] Noel T. Whelan,et al. Therapeutic photobiomodulation for methanol-induced retinal toxicity , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] T. Dawson,et al. Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease , 2000, Neurobiology of Disease.
[20] Noel T. Whelan,et al. Effect of NASA light-emitting diode irradiation on wound healing. , 2001, Journal of clinical laser medicine & surgery.
[21] Rong Ying,et al. Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone- and MPP+-induced neurotoxicity , 2008, Brain Research.
[22] N. Wood,et al. Molecular pathogenesis of Parkinson's disease. , 2005, Human molecular genetics.
[23] T. Karu,et al. Primary and secondary mechanisms of action of visible to near-IR radiation on cells. , 1999, Journal of photochemistry and photobiology. B, Biology.
[24] Rina Das,et al. Effect of NASA light-emitting diode irradiation on molecular changes for wound healing in diabetic mice. , 2003, Journal of clinical laser medicine & surgery.
[25] Y. Yang,et al. Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation. , 2000, Neuroscience.
[26] M. Beal,et al. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.
[27] U. Oron,et al. Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy , 2009, Molecular Neurodegeneration.
[28] M. Chesselet,et al. Genetic mouse models of parkinsonism: Strengths and limitations , 2005, NeuroRX.
[29] R. Gainetdinov,et al. Dopamine Transporter Is Required for In Vivo MPTP Neurotoxicity: Evidence from Mice Lacking the Transporter , 1997, Journal of neurochemistry.
[30] M. Wong-Riley,et al. Harnessing the cell's own ability to repair and prevent neurodegenerative disease. , 2008, SPIE newsroom.